Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ZOL 446

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Bisphosphonates are used to treat bone diseases such as osteoporosis and cancer-induced bone pain and fractures. It is thought… Expand
2017
2017
The development of phosphonate-metal materials is tightly related to the advancement in their synthesis methods. Herein, using… Expand
2016
2016
Once bone metastasis occurs, the chances of survival and quality of life for cancer patients decrease significantly. With the… Expand
2016
2016
Nitrogen-containing bisphosphonates (N-BP), including zoledronic acid (ZOL) and alendronate (ALD), have been proposed as… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2015
2015
Abstract In this study, we investigated the possibility of whether depletion of tumor-associated macrophages (TAMs) by zoledronic… Expand
Highly Cited
2013
Highly Cited
2013
BACKGROUND Zoledronic acid (Zol) is a potent inhibitor of farnesyl-pyrophosphate synthase with broad clinical use in the… Expand
2008
2008
Zoledronic acid (Zometa, ZOL) and cytotoxic chemotherapy agents have been reported to have synergistic antitumor activities… Expand
  • table I
  • figure 2
  • figure 1
  • table II
  • table III
1998
1998
espanolSe presenta un caso de paracoccidioidomicosis con manifestaciones iniciales a nivel de la mucosa bucal en un paciente… Expand
1992
1992
  • N. Hou, L. Xu
  • Yao xue xue bao = Acta pharmaceutica Sinica
  • 1992
  • Corpus ID: 43489074
4-amino-3-(furan-2)-5-mercapto-1,2,4-triazole (Ia) and its ten Schiff bases derived from Ia with different aldehydes were… Expand
Highly Cited
1975
Highly Cited
1975
'101 The prostaglandins are potent autacoids which are widely distributed in mammalian tissues [I] including the central nervous… Expand